IMVT-1402

DB21979InvestigationalProtein Based Therapies

IMVT-1402 is under investigation in clinical trial NCT06754462 (A Study to Evaluate the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Active, Difficult to Treat Rheumatoid Arthritis).

Mechanism: Pharmacologically active on IgG receptor FcRn large subunit p51
Curator reviewed
Code names: IMVT-1402

Resolves to

Targets

P55899FCGRT

What you can answer from here — as of July 02, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

7Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with IMVT-1402, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account